Clinical Trial Underway on pTeroPure

OXFORD, Miss.A clinical study has been initiated at the University of Mississippi (UM) to investigate the effects of pTeroPure pterostilbene on various markers of heart health in subjects with lipid disorders. Ole Miss holds the patent rights to the compound, and has granted the exclusive worldwide license to those rights to ChromaDex Corp., Irvine, Calif.

The study is being conducted at the UM Medical Center in Jackson, Miss.; patients will receive high and low doses of pterostilbene, with and without grape extract, or a placebo. Daniel Riche, Ph.D., the studys principal investigator, said the first clinical investigation into pterostilbenes effects in humans is an exciting endeavor. He said, Pterostilbene has significant promise, and we hope it will offer a useful non-prescription option for metabolic disorders. In addition to cholesterol and blood pressure, we will be evaluating urine tests and monitoring for inflammatory markers. Reductions in these markers may correlate with improvements in oxidative stress."

Pterostilbene is chemically related to resveratrol, a compound that can be found in grapes, blueberries and other small fruits, as well as the bark of some trees. In laboratory tests, pterostilbene has shown promise for improving cardiovascular health, glucose levels, anti-aging and cognitive function.

The commencement of our pTeroPure pterostilbene clinical study with the University of Mississippi marks another significant milestone for ChromaDex," said Frank Jaksch, CEO and co-founder of ChromaDex. Most people may not yet know of pterostilbene, but we believe this naturally occurring compounds improved activity and potency may soon make it as well known as its highly-successful, well known relative, resveratrol."